NASDAQ:MRNA
Moderna Stock News
$103.44
-0.350 (-0.337%)
At Close: Apr 17, 2024
Moderna to Report First Quarter 2024 Financial Results on Thursday, May 2, 2024
07:00am, Wednesday, 17'th Apr 2024
CAMBRIDGE, MA / ACCESSWIRE / April 17, 2024 / Moderna, Inc. (NASDAQ:MRNA), today announced that it will host a live conference call and webcast at 8:00 a.m. ET on Thursday, May 2, 2024 to report its f
Moderna, Inc. (MRNA) is Attracting Investor Attention: Here is What You Should Know
10:05am, Tuesday, 16'th Apr 2024
Moderna (MRNA) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
2 Artificial Intelligence (AI) in Healthcare Stocks to Buy and Hold for Great Long-Term Potential
04:55am, Tuesday, 16'th Apr 2024
AI could solve one of the biggest problems in drug development: the lengthy time it takes to bring a product to market. The AI in healthcare market is set to expand at a compound annual growth rate of
1 New Green Flag for Moderna and Merck Stock
08:45am, Friday, 12'th Apr 2024
Moderna and Merck are collaborating on a personalized cancer vaccine. That vaccine program just disclosed some new data from the clinic.
Moderna (MRNA) Stock Dips While Market Gains: Key Facts
07:06pm, Thursday, 11'th Apr 2024
Moderna (MRNA) closed the most recent trading day at $107.01, moving -0.12% from the previous trading session.
3 Pharma Stocks to Sell in April Before They Crash & Burn
02:10pm, Thursday, 11'th Apr 2024
There are some pharma stocks to sell in April. Holding these companies is too risky, especially as the industry faces increasing regulatory scrutiny and pricing pressures.
If You Can Only Buy One Biotech Stock in April, It Better Be One of These 3 Names
01:49pm, Thursday, 11'th Apr 2024
Biotech stocks are one of the hottest investing opportunities in the stock marketlately. The optimism surrounding the industry is evident in the SPDR S&PBiotech ETF's (NYSEARCA: XBI ) 25% bump in valu
Moderna halts plans to build Kenya vaccine plant as Covid shot demand plunges
12:16pm, Thursday, 11'th Apr 2024
Moderna's decision aligns with its broader effort to cut costs by resizing its Covid vaccine manufacturing footprint.
Moderna (MRNA) Up 6% on Upbeat Data From Cancer Jab Study
12:01pm, Wednesday, 10'th Apr 2024
Data from an early-stage study shows that treatment with Moderna's (MRNA) experimental cancer therapy achieved positive clinical response in patients with a specific type of head and neck cancer.
Moderna (MRNA) Surges 6.2%: Is This an Indication of Further Gains?
07:41am, Wednesday, 10'th Apr 2024
Moderna (MRNA) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
Among the biggest winners today are some major long-term losers, says Jim Cramer
07:41pm, Tuesday, 09'th Apr 2024
'Mad Money' host Jim Cramer looks at today's market winners and losers.
Moderna Reports Positive Results from Cancer Vaccine-Keytruda Combination Trial
05:36pm, Tuesday, 09'th Apr 2024
Moderna (MRNA) shares jumped Tuesday after the biotech firm reported positive results from a small trial involving those with head and neck cancers treated with its experimental individualized MRNA ca
S&P 500 Gains and Losses Today: Moderna Soars as Cancer Vaccine Shows Promise
05:15pm, Tuesday, 09'th Apr 2024
Major U.S. equities made little headway in the session preceding the release of Consumer Price Index (CPI) report for March.
Moderna's stock jumps 6% as its cancer vaccine could treat more than just melanoma
02:56pm, Tuesday, 09'th Apr 2024
Moderna Inc.'s stock jumped 6% Tuesday to lead S&P 500 gainers, after the company shared cancer-vaccine data that suggests it may work in indications outside its target of melanoma.
What made Moderna stock pop 10% on Tuesday?
12:37pm, Tuesday, 09'th Apr 2024
Moderna Inc (NASDAQ: MRNA) popped as much as 10% on Tuesday after a Jefferies analyst made upbeat remarks on new data for its experimental vaccine for head and neck cancer.